Ortho Clinical Diagnostics Holdings plc CEO Christopher Smith receives $6.2M in 2021

Ortho Clinical Diagnostics Holdings plc reports 2021 executive compensation

By ExecPay News

Published: May 2, 2022

Ortho Clinical Diagnostics Holdings plc reported fiscal year 2021 executive compensation information on May 2, 2022.

In 2021, five executives at Ortho Clinical Diagnostics Holdings plc received on average a compensation package of $2.5M.

Average pay of disclosed executives at Ortho Clinical Diagnostics Holdings plc

Christopher Smith, Chief Executive Officer, received $6.2M in total. 32% of Smith's compensation, or $2M, was in bonus. Smith also received $1.3M in non-equity incentive plan, $1.3M in salary, $1.5M in stock awards, as well as $121K in other compensation.

Michael Iskra, Executive Vice President, Strategy & Commercial Excellence, received a compensation package of $3.9M. 78% of the compensation package, or $3M, was in stock awards.

Michael A. Schlesinger, General Counsel, earned $922K in 2021.

Joseph Busky, Chief Financial Officer, received $734K in 2021.

Chockalingam Palaniappan, Chief Innovation Officer, earned $726K in 2021.

Ortho Clinical Diagnostics Holdings plc's fiscal year ends on January 2.